5UJ3
Crystal structure of the KPC-2 beta-lactamase complexed with hydrolyzed cefotaxime
Summary for 5UJ3
Entry DOI | 10.2210/pdb5uj3/pdb |
Related | 5UJ4 5UL8 |
Descriptor | Carbapenem-hydrolyzing beta-lactamase KPC, (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}(carboxy)methyl]-5-methylidene-5,6-dihydro -2H-1,3-thiazine-4-carboxylic acid, GLYCEROL, ... (4 entities in total) |
Functional Keywords | carbapenemase, cefotaxime, beta-lactamase, complex, hydrolase-antibiotic complex, hydrolase/antibiotic |
Biological source | Klebsiella pneumoniae |
Total number of polymer chains | 1 |
Total formula weight | 31725.58 |
Authors | Pemberton, O.A.,Chen, Y. (deposition date: 2017-01-16, release date: 2017-04-26, Last modification date: 2024-10-16) |
Primary citation | Pemberton, O.A.,Zhang, X.,Chen, Y. Molecular Basis of Substrate Recognition and Product Release by the Klebsiella pneumoniae Carbapenemase (KPC-2). J. Med. Chem., 60:3525-3530, 2017 Cited by PubMed Abstract: Carbapenem-resistant Enterobacteriaceae are resistant to most β-lactam antibiotics due to the production of the Klebsiella pneumoniae carbapenemase (KPC-2) class A β-lactamase. Here, we present the first product complex crystal structures of KPC-2 with β-lactam antibiotics containing hydrolyzed cefotaxime and faropenem. They provide experimental insights into substrate recognition by KPC-2 and its unique cephalosporinase/carbapenemase activity. These structures also represent the first product complexes for a wild-type serine β-lactamase, elucidating the product release mechanism of these enzymes in general. PubMed: 28388065DOI: 10.1021/acs.jmedchem.7b00158 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.45 Å) |
Structure validation
Download full validation report
